Related Experiment Video
Updated: Oct 27, 2025

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
Transthyretin-mediated protein and peptide oligomerization for enhanced target clustering
Daniel Yoo1, Kenneth W Walker1
1Amgen Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, U.S.A.
Abstract:
Advances in cancer research have led to the development of new therapeutics with significant and durable responses such as immune checkpoint inhibitors. More recent therapies aim to stimulate anti-tumor immune responses by targeting the tumor necrosis factor (TNF) receptors, however this approach has been shown to require clustering of receptors in order to achieve a significant response. Here we present a perspective on using transthyretin, a naturally occurring serum protein, as a drug delivery platform to enable cross-linking independent clustering of targets. TTR forms a stable homo-tetramer with exposed termini that make TTR a highly versatile platform for generating multimeric antibody fusions to enable enhanced target clustering. Fusions with antibodies or Fabs targeting TRAILR2 were shown to have robust cytotoxic activity in vitro and in vivo in colorectal xenograft models demonstrating that TTR is a highly versatile, stable, therapeutic fusion platform that can be used with antibodies, Fabs and other bioactive fusion partners and has broad applications in oncology and infectious disease research.
Insights
Researchers developed a novel drug delivery platform using transthyretin (TTR) to enhance anti-tumor immune responses. This TTR-based system effectively clusters targets, showing promise for new cancer therapies and infectious disease research.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer therapies like immune checkpoint inhibitors have shown success.
- Targeting tumor necrosis factor (TNF) receptors aims to boost anti-tumor immunity but requires receptor clustering.
- Existing methods for receptor clustering can be complex and challenging.
Purpose of the Study:
- To present transthyretin (TTR) as a drug delivery platform for cross-linking independent target clustering.
- To demonstrate the versatility and stability of TTR for creating multimeric antibody fusions.
- To evaluate the therapeutic potential of TTR-based fusions in cancer models.
Main Methods:
- Utilized transthyretin (TTR), a stable serum protein tetramer, as a fusion platform.
- Engineered antibody or Fab fusions targeting TRAILR2.
- Assessed cytotoxic activity of TTR fusions in vitro and in vivo using colorectal xenograft models.
Main Results:
- Transthyretin (TTR) demonstrated a versatile and stable platform for generating multimeric antibody fusions.
- TTR-TfR2 antibody/Fab fusions exhibited robust cytotoxic activity against cancer cells.
- Effective in vitro and in vivo anti-tumor activity was observed in colorectal cancer models.
Conclusions:
- Transthyretin (TTR) is a highly versatile and stable therapeutic fusion platform.
- TTR enables enhanced target clustering, crucial for TNF receptor-based therapies.
- This platform has broad applications in oncology and infectious disease research.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Protein Transport to the Thylakoids
Export of Misfolded Proteins out of the ER
Tail-anchoring of Proteins in the ER Membrane
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...

